Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers.
AUTOR(ES)
Sitzmann, J V
RESUMO
OBJECTIVE: To characterize angiotensin-II receptor density and affinity in normal and cirrhotic livers and in hepatocellular and metastatic colorectal cancer. SUMMARY BACKGROUND DATA: Several studies have indicated a possible beneficial effect of angiotensin-II as a biologic response modifier in the treatment of hepatic or metastatic colon cancer. This is based on evidence that angiotensin-II will cause a selective increase in arterial vasoconstriction in normal liver compared with tumor. METHODS: Human hepatoma (5), metastatic colon (10), or cirrhotic (3) liver was obtained. Non-tumor-bearing regions served as normal liver. Angiotensin-II receptor binding was determined on membranes with 125I-angiotensin-II and in situ studies were performed using the biotin-avidin detection system. RESULTS: Angiotensin-II receptor density was markedly down-regulated in tumor compared with normal or cirrhotic liver. CONCLUSIONS: A loss of angiotensin-II receptors occurs on the neovasculature of hepatic tumors.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1243178Documentos Relacionados
- Neurotensin expression and release in human colon cancers.
- Modulation of Cyclic Nucleotides in Isolated Rat Glomeruli: ROLE OF HISTAMINE, CARBAMYLCHOLINE, PARATHYROID HORMONE, AND ANGIOTENSIN-II
- Advances in the screening and staging of colon and rectal cancers.
- Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer.
- Oncornavirus-like particles in human skin cancers.
